Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

Nanthealth Inc.

Start price
Target price
Perf. (%)
€10.36
05.04.22
€15.00
05.04.23
-23.68%
22.08.22

buy
Chemocentryx Inc.

Start price
Target price
Perf. (%)
€29.94
20.10.21
€35.00
31.12.23
65.15%
05.08.22

Could be very worthwhile Investment >20% year
buy
Forte Biosciences Inc.

Start price
Target price
Perf. (%)
€1.19
27.06.22
€1.00
27.06.23
26.17%
09.07.22

Capable Management
Could be very worthwhile Investment >20% year
Few uniques
buy
Agile Therapeutics Inc.

Start price
Target price
Perf. (%)
€79.50
27.06.22
€100.00
27.06.23
40.88%
28.06.22

Could be worthwhile Investment >10% per year
Capable Management
Very good company culture
Little innovation
buy
Kezar Life Sciences

Start price
Target price
Perf. (%)
€10.20
16.11.21
€11.00
31.12.24
0.98%
28.06.22

Could be very worthwhile Investment >20% year
buy
Forte Biosciences Inc.

Start price
Target price
Perf. (%)
€1.10
13.06.22
€1.00
13.06.23
7.81%
25.06.22

Capable Management
Could be very worthwhile Investment >20% year
Few uniques
buy
Kadmon Holdings LLC

Start price
Target price
Perf. (%)
€3.12
17.05.21
€4.00
17.05.22
162.71%
18.05.22

buy
Zosano Pharma Corp.

Start price
Target price
Perf. (%)
€1.43
02.05.22
€1.00
02.05.23
18.02%
05.05.22

Could be worthwhile Investment >10% per year
Capable Management
Good culture
Growths slower than the competition
buy
Aveo Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€3.64
09.01.22
€4.00
09.01.23
37.21%
21.03.22

buy
Avenue Therapeutics Inc.

Start price
Target price
Perf. (%)
€0.015
20.02.22
€7.50
20.03.22
61900.00%
21.03.22

Could be worthwhile Investment >10% per year
buy
Chemocentryx Inc.

Start price
Target price
Perf. (%)
€11.37
17.06.21
€18.00
09.03.22
95.60%
10.03.22

Could be very worthwhile Investment >20% year
buy
Epizyme Inc.

Start price
Target price
Perf. (%)
€1.10
27.01.22
€1.00
27.01.23
41.00%
05.02.22

Could be worthwhile Investment >10% per year
Capable Management
Bad culture
Nanthealth Inc.

Start price
Target price
Perf. (%)
€22.50
21.09.21
€15.00
21.09.22
-44.57%
08.01.22

buy
Catalyst Pharmaceutical Partners Inc

Start price
Target price
Perf. (%)
€2.84
05.01.21
€3.50
05.01.22
100.71%
06.01.22

buy
Intellia Therapeutics Inc

Start price
Target price
Perf. (%)
€46.03
04.01.21
€60.00
04.01.22
115.51%
05.01.22

buy
Misonix Inc.

Start price
Target price
Perf. (%)
€10.70
17.12.20
€12.00
17.12.21
103.74%
18.12.21

buy
MannKind Corp.

Start price
Target price
Perf. (%)
€2.99
16.12.20
€3.50
16.12.21
20.27%
17.12.21

buy
Amphastar Pharmaceuticals Inc

Start price
Target price
Perf. (%)
€15.30
15.12.20
€18.00
15.12.21
28.10%
16.12.21

buy
Ardelyx Inc.

Start price
Target price
Perf. (%)
€0.99
30.11.21
€1.00
30.11.22
36.36%
11.12.21

Could be very worthwhile Investment >20% year
Good culture
Innovative
Few uniques
buy
Avid Bioservices Inc

Start price
Target price
Perf. (%)
€8.05
03.12.20
€9.00
03.12.21
200.62%
04.12.21

buy
Axonics Modulation Technologies Inc

Start price
Target price
Perf. (%)
€37.20
28.11.20
€42.00
28.11.21
31.72%
29.11.21

Could be worthwhile Investment >10% per year
buy
Evolent Health Inc

Start price
Target price
Perf. (%)
€9.10
24.10.20
€11.00
04.11.21
190.11%
05.11.21

buy
Capital Senior Living Corp.

Start price
Target price
Perf. (%)
€7.50
22.10.20
€15.00
04.11.21
230.67%
05.11.21

buy
Anavex Life Sciences Corp

Start price
Target price
Perf. (%)
€4.28
21.10.20
€6.00
04.11.21
348.60%
05.11.21

Could be worthwhile Investment >10% per year
buy
Cytokinetics Inc.

Start price
Target price
Perf. (%)
€14.20
16.10.20
€18.00
04.11.21
143.66%
05.11.21